Previous Article | Next Article ![]()
Infection and Immunity, January 2001, p. 148-153, Vol. 69, No. 1
Division of Infectious Diseases, Department
of Medicine,1 Department of Microbiology
and Immunology,2 and Department of
Pathology,3 Albert Einstein College of Medicine,
Bronx, New York 10461
Received 9 August 2000/Returned for modification 16 September
2000/Accepted 11 October 2000
The ability of Toxoplasma gondii tachyzoites to
differentiate into latent bradyzoite forms is essential for
pathogenesis of clinical disease. We examined the effects of cyclic
nucleotides on T. gondii bradyzoite differentiation in
vitro. Differentiation of tachyzoites to bradyzoites was measured in an
immunofluorescence assay using ME49 or its clonal derivative PLK, two
well-characterized T. gondii strains. Treatment of human
fibroblast cultures infected with T. gondii with
8-(4-chlorophenylthio)-cyclic GMP (CPT-cGMP), a membrane-permeable,
nonhydrolyzable analogue of cGMP, resulted in an increased percentage
of bradyzoite-positive vacuoles. Cyclic AMP (cAMP) also induced in
vitro conversion of PLK, but the method of cAMP elevation was critical.
Forskolin raises cAMP levels transiently and induced bradyzoites,
whereas agents predicted to cause sustained elevation of cAMP were
inhibitory to parasite conversion. Levels of cAMP were measured in host
cells and extracellular tachyzoites. Forskolin, CPT-cGMP, and agents
known to induce bradyzoite formation elevated cAMP in host cells and
PLK parasites. These data suggest cyclic nucleotide signaling pathways
are important in the stress-induced conversion of T. gondii
tachyzoites to bradyzoites. Furthermore, because cAMP elevation was
seen in PLK but not RH, a T. gondii strain that did not
differentiate well in our assay, cAMP signaling within the parasite is
likely to be critical.
Toxoplasma gondii is an
obligate intracellular apicomplexan parasite responsible for
encephalitis in immunocompromised individuals and birth defects in
children infected in utero. Although some individuals present with
toxoplasmosis during acute infection, most clinically apparent disease
results from reactivation of dormant bradyzoites and their conversion
to tachyzoites. Unchecked multiplication of the rapidly growing
tachyzoite is thought to be responsible for disease, and control of
tachyzoites by the immune system results in their conversion to latent
bradyzoite forms. Thus, elucidation of the signaling pathways
responsible for tachyzoite-bradyzoite interconversion is critical for
understanding pathogenesis of toxoplasmosis.
Recent studies by several investigators have established that a variety
of stress conditions including pH shock, heat shock, mitochondrial
inhibitors, chemical stress, and nitric oxide induce bradyzoite
formation (2, 3, 21, 23). Induction of a variety of heat
shock proteins (HSPs) including HSP70 is associated with bradyzoite
transition (19, 25), and knockout of a bradyzoite-specific small HSP gene, BAG1, results in reduced numbers of
bradyzoites in mouse brains (29). These data collectively
suggest that the transition from tachyzoite to bradyzoite is a
stress-induced differentiation response. Because of the remarkable
conservation of cyclic nucleotide signaling pathways in the stress
response in a wide variety of organisms including other eukaryotic
pathogens, we examined the role of cyclic nucleotide signaling in
bradyzoite differentiation in T. gondii.
Our data suggest that both cyclic GMP (cGMP) and cyclic AMP (cAMP) can
induce bradyzoite formation. These effects could be due to an increase
in host or parasite cyclic nucleotides. PLK, a T. gondii
strain able to differentiate in vitro, exhibited a rise in cAMP in
response to bradyzoite-inducing conditions, but elevation of cAMP under
the same conditions was not evident in RH, a strain that does not
differentiate well. These data suggest that cAMP elevation within the
parasite may be important for bradyzoite differentiation.
Parasite and tissue culture.
ME49, PLK (a clonal derivative
of ME49 [10]), and RH were the three T. gondii strains used. PLK parasites had been previously passaged
though mice and were known to generate cysts efficiently in vivo
(29). Parasites were maintained by serial passage in confluent monolayers of human foreskin fibroblasts (HFF) grown in
Dulbecco's modified Eagle's medium (Gibco BRL, Grand Island, N.Y.)
supplemented with 10% fetal bovine serum (Gibco BRL) and 1%
penicillin-streptomycin (Gibco BRL).
Materials.
Forskolin, 1-methyl-3-isobutylxanthine (IBMX),
8-(4-chlorophenylthio)-cAMP (CPT-cAMP), 8-(4-chlorophenylthio)-cGMP
(CPT-cGMP), and sodium nitroprusside (SNP) were obtained from
Sigma (St. Louis, Mo.).
LY83583 (6-anilino-5,8-quinolinequinone) and 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1- one
(ODQ) were obtained from Calbiochem (La Jolla, Calif.). Forskolin, CPT-cAMP, CPT-cGMP, and IBMX were dissolved in dimethyl sulfoxide; SNP
was dissolved in Dulbecco's modified Eagle's medium.
In vitro bradyzoite assay.
T. gondii in vitro
differentiation assays were performed using an indirect
immunofluorescence assay as described by Weiss et al.
(23). Approximately 4,000 parasites were inoculated with the agent to be tested onto confluent HFF monolayers growing in four-chambered coverglass slides or Permanox slides (Lab-Tek; Fisher
Scientific, Pittsburgh, Pa.). Each condition to be analyzed was set up
in duplicate for each experiment. Cultures were grown for 2 or 3 days.
(Cultures were monitored daily and fixed when tachyzoite vacuoles were
on the verge of lysing [generally 2 days for RH and 3 days for PLK].)
Fixation of cultures at 1 day was not routinely performed because
staining was frequently weak or uneven and SNP-induced vacuoles were
often too small to count reliably.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.1.148-153.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Cyclic Nucleotide Signaling in Toxoplasma
gondii Bradyzoite Differentiation
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Cyclic nucleotide measurements.
Freshly lysed RH, PLK, and
ME49 strains of T. gondii were purified from host cells by
serial passage through 20-, 23-, 25-, and 27-gauge needles and
filtration through a 3.0-µm-pore-size Nuclepore filter. Parasites
were washed and resuspended in complete medium supplemented with the
agents to be tested. Incubations were performed at 37°C in a
CO2 incubator to maintain normal medium pH. At 15, 30, and
60 min, cells were placed in 20 mM phosphate buffer (pH 7.0) containing
20 mM EDTA and 1 mM IBMX. The cells were then boiled for 7 min and
quick cooled on ice. The extract was briefly centrifuged, and then the
supernatant was stored at
20°C. Cyclic nucleotide levels were
measured in duplicate using the cGMP and cAMP enzyme immunoassay (EIA)
kits from Stratagene (La Jolla, Calif.) following the manufacturer's
instructions. cGMP samples were acetylated prior to testing, and cAMP
levels were measured with nonacetylated samples. Absolute levels of
cyclic nucleotide were calculated by comparison to a standard curve
generated during each experiment.
| |
RESULTS |
|---|
|
|
|---|
In vitro bradyzoite induction assay. DBA lectin reactivity has been reported to be a sensitive early marker of bradyzoite differentiation similar to BAG1 and p36/BSR4 (4). The lectin recognizes carbohydrate modifications of a 116-kDa cyst wall glycoprotein previously identified with bradyzoite-specific monoclonal antibody 73.18 (24, 28). We adapted DBA to the in vitro differentiation assay. In our hands, DBA gave results similar to those obtained with BAG1 immunostaining (23).
Induction of bradyzoite formation by cyclic nucleotides.
Initially, the membrane-permeable nonhydrolyzable forms of cAMP and
cGMP, CPT-cAMP and CPT-cGMP, were compared to control medium for the
ability to induce bradyzoite conversion in culture. Parasites were
infected onto HFF in medium supplemented with the agent to be tested
and then grown for 3 days or until tachyzoites had begun to lyse. Each
condition was tested in duplicate. Bradyzoite-positive vacuoles were
counted for each experiment and compared to the control cultures.
Cultures with SNP, which induces bradyzoite formation, were analyzed in
parallel. Results from a representative experiment are shown in Table
1.
|
|
Effects of guanylate cyclase inhibitors. Nitric oxide exerts some of its effects on cells by sequestering the heme group in soluble guanylate cyclase, leading to cyclase activation and increased levels of cGMP. The downstream effects of cGMP can be mediated by activation of cGMP-dependent kinase and either activation or inhibition of phosphodiesterase activity. Therefore, we tested the effects of the soluble guanylate cyclase inhibitors LY83583 (1) and ODQ (7, 18) on bradyzoite differentiation.
Induction of bradyzoite vacuoles by 100 µM SNP was inhibited by 1 µM LY83583 (1.1-fold induction compared to untreated controls; n = 4). Incubation of 1 mM cGMP (or a nonhydrolyzable cGMP analogue) with 1 µM LY83583 and 100 µM SNP restored bradyzoite differentiation to levels seen with 100 µM SNP alone. LY83583 at 1 µM had no effect on pH 8.1 induction of bradyzoite vacuoles. Because LY83583 has other effects (discussed in reference 7), we tested ODQ, which is reported to be an irreversible and more specific inhibitor of soluble guanylate cyclase (7, 18); 50 µM ODQ inhibited induction of bradyzoites by 100 µM SNP. The effects exerted by LY83583 and ODQ, however, are likely to be complex. Unlike LY83583, 50 µM ODQ alone induced bradyzoite formation to levels comparable to that induced by SNP.Cyclic nucleotide measurements.
Cyclic nucleotide levels were
measured in PLK and RH strain extracellular parasites as well as host
cells by using cAMP and cGMP EIA assays. Samples were tested at 15, 30, and 60 min. For all conditions tested, absolute cGMP levels were lower
than cAMP levels, and acetylated cGMP samples were used for detection.
Acetylation increases the sensitivity of the assay at least 10-fold
(Stratagene cAMP and cGMP EIA user manual). Host cells (HFF) exhibited
cAMP elevation in response to 100 µM SNP, 100 µM forskolin, and pH 8.1 (Fig. 1). In HFF, SNP consistently
led to an elevation of cGMP, but consistent results were not seen in
response to other bradyzoite-inducing conditions (data not shown).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Studies from a number of laboratories suggest that bradyzoite formation is a response of parasites to environmental stress. Although changes in the parasite's environment frequently reflect changes in the host cell, there need not be changes in the host cell for bradyzoite induction to occur. Exposure of extracellular parasites to stress-inducing bradyzoite conditions is sufficient to induce bradyzoite differentiation whether pH induction or SNP is used (25). These data suggest that parasites sense and respond to changes in their extracellular environment by differentiating into bradyzoites and that continuous induction is not necessary. Similarly, Yahiaoui et al. (27) found that parasites incubated in media extracellularly for 12 h efficiently differentiated into bradyzoites once inoculated onto HFF grown in normal media.
Our studies indicate that both cGMP and cAMP can mediate bradyzoite
differentiation, and data from other systems suggest that these
signaling pathways are likely to interact. It remains to be determined
whether these effects are extracellular (i.e., host mediated),
intracellular (i.e., within the parasite), or, more likely, due to
stimulation of both host and parasite signaling pathways. It is likely
that bradyzoite differentiation involves the interaction of multiple
host and parasite signaling pathways including both cGMP and cAMP
pathways (Fig. 3).
|
HFF generated a significant cAMP elevation after exposure to conditions associated with bradyzoite induction. It is likely that host cell environments including cAMP elevations contribute to the bradyzoite differentiation process. It is not known if T. gondii has a receptor or sensor for cyclic nucleotides in its extracellular environment. In Dictyostelium, cAMP secreted into the environment binds to cAMP receptors to regulate the differentiation program of cells within the fruiting body (20). A similar pathway may also be important in T. gondii, but elevation in host cell cAMP does not appear to be sufficient for differentiation given that T. gondii RH differentiated much less efficiently than T. gondii PLK or ME49.
The role of cGMP in T. gondii bradyzoite differentiation remains to be clarified. CPT-cGMP consistently induced PLK tachyzoites to differentiate into bradyzoites. CPT-cGMP also elevated cAMP levels in parasites, suggesting that cGMP effects may be due to regulation of cAMP levels. We addressed the role of cGMP in bradyzoite differentiation by using inhibitors of guanylate cyclase. While these experiments are consistent with a role for cGMP in nitric oxide-mediated bradyzoite induction, the effects of these inhibitors was complex and effects on other signaling molecules cannot be ruled out.
A cAMP response within the parasite may be associated with differentiation. We could not generate a significant cAMP response in RH parasites, but our RH isolate did not differentiate well under any conditions tested. In contrast, PLK parasites had a significant elevation in intracellular cAMP levels in conditions known to induce bradyzoite differentiation and were able to differentiate efficiently. Because the cyclic nucleotide measurements were performed on a population of cells, we were unable to determine if the small subpopulation of RH parasites differentiating to bradyzoites had changes in cyclic nucleotide levels.
It seems likely that cAMP has both stimulatory and antagonistic effects on bradyzoite differentiation. While both forskolin and IBMX elevated cAMP in parasites, only forskolin induced bradyzoite formation. Since IBMX, which inhibits cAMP degradation, blocked bradyzoite induction by forskolin, the degree of cAMP elevation or kinetics of cAMP elevation may be critical. It may be that sustained elevation of cAMP leads to activation of pathways that are inhibitory to bradyzoite differentiation. In support of this hypothesis, CPT-cAMP, which is not degraded by phosphodiesterases, was also inhibitory for bradyzoite formation. Signaling molecules such as the mitogen-activated protein kinase KSS1 (6, 13) and cAMP-dependent kinases (14, 17) have been described to have both positive and negative regulatory effects in stress-induced pseudohyphal differentiation in Saccharomyces cerevisiae.
Studies of many pathogens have correlated cAMP signaling with differentiation. cAMP signaling has been implicated in Plasmodium falciparum differentiation to gametocytes (11), but as with T. gondii, cAMP effects have not been observed in all strains (5, 9). cAMP signaling has also been found to be critical for virulence in a number of fungal pathogens, including Cryptococcus neoformans and Candida albicans (12).
Our data would predict that T. gondii protein kinase A (PKA) plays a significant role in the conversion of tachyzoites to bradyzoite forms. In P. falciparum, a correlation between PKA levels and ability to transform into gametocytes has been described (16). PKA could have stimulatory or inhibitory effects on bradyzoite gene transcription or effects on other kinases important in cell fate decisions and stress-induced differentiation (8) such as the T. gondii GSK3/shaggy homologue TPK3 (15, 26) (Fig. 3). Recent data for S. cerevisiae reveal that one of the three PKA catalytic subunits mediates stress-induced differentiation (14, 17), and studies of Dictyostelium have suggested that cAMP is not required for differentiation if sufficient levels of PKA activity are present (22).
Studies in other organisms suggest that the signaling pathways utilized by eukaryotic pathogens in response to stress are phylogenetically conserved and significantly affect virulence and pathogenicity. Further studies of T. gondii will be needed to clarify the complex interactions of cGMP and cAMP signaling molecules with upstream sensors and downstream effector molecules.
| |
ACKNOWLEDGMENTS |
|---|
L.A.K. is a Howard Hughes Medical Student Scholar. K.K. is a Burroughs Wellcome New Investigator in Molecular Parasitology. This study was supported by Public Health Service grants AI41058 (K.K.), AI01535 (K.K.), and AI39454 (L.M.W.) from the National Institute of Allergy and Infectious Diseases.
We thank Jianzhong Tang, Yan Fen Ma, and Denise LaPlace for expert technical assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Ullmann 1225, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461. Phone: (718) 430-2611. Fax: (718) 430-8968. E-mail: kkim{at}aecom.yu.edu.
Editor: W. A. Petri Jr.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Beasley, D., J. H. Schwartz, and B. M. Brenner. 1991. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J. Clin. Investig. 87:602-608. |
| 2. |
Bohne, W.,
J. Heesemann, and U. Gross.
1993.
Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages.
Infect. Immun.
61:1141-1145 |
| 3. |
Bohne, W.,
J. Heesemann, and U. Gross.
1994.
Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion.
Infect. Immun.
62:1761-1767 |
| 4. |
Boothroyd, J. C.,
M. Black,
S. Bonnefoy,
A. Hehl,
L. J. Knoll,
I. D. Manger,
E. Ortega-Barria, and S. Tomavo.
1997.
Genetic and biochemical analysis of development in Toxoplasma gondii.
Philos. Trans. R. Soc. Lond. B
352:1347-1354 |
| 5. | Brockelman, C. R. 1982. Conditions favoring gametocytogenesis in the continuous culture of Plasmodium falciparum. J. Protozool. 29:454-458[Medline]. |
| 6. | Cook, J. G., L. Bardwell, and J. Thorner. 1997. Inhibitory and activating functions for MAPK Kss1 in the S. cerevisiae filamentous-growth signalling pathway. Nature 390:85-88[CrossRef][Medline]. |
| 7. | Garthwaite, J., E. Southam, C. L. Boulton, E. B. Nielsen, K. Schmidt, and B. Mayer. 1995. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48:184-188[Abstract]. |
| 8. | Harwood, A., S. Plyte, J. Woodgett, H. Strutt, and R. Kay. 1995. Glycogen synthase kinase-3 regulates cell fate in Dictyostelium. Cell 80:139-148[CrossRef][Medline]. |
| 9. | Inselburg, J. 1983. Stage-specific inhibitory effect of cyclic AMP on asexual maturation and gametocyte formation of Plasmodium falciparum. J. Parasitol. 69:592-597[CrossRef][Medline]. |
| 10. | Kasper, L., and P. Ware. 1985. Recognition and characterization of stage-specific oocyst/sporozoite antigens of Toxoplasma gondii. J. Clin. Investig. 75:1570. |
| 11. | Kaushal, D. C., R. Carter, L. H. Miller, and G. Krishna. 1980. Gametocytogenesis by malaria parasites in continuous culture. Nature 286:490-492[CrossRef][Medline]. |
| 12. | Madhani, H. D., and G. R. Fink. 1998. The control of filamentous differentiation and virulence in fungi. Trends Cell Biol. 8:348-353[CrossRef][Medline]. |
| 13. | Madhani, H. D., C. A. Styles, and G. R. Fink. 1997. MAP kinases with distinct inhibitory functions impart signaling specificity during yeast differentiation. Cell 91:673-684[CrossRef][Medline]. |
| 14. |
Pan, X., and J. Heitman.
1999.
Cyclic AMP-dependent protein kinase regulates pseudohyphal differentiation in Saccharomyces cerevisiae.
Mol. Cell. Biol.
19:4874-4887 |
| 15. | Qin, C.-l., J. Tang, and K. Kim. 1998. Cloning and in vitro expression of TPK3, a Toxoplasma gondii homologue of shaggy/glycogen synthase kinase-3 kinases. Mol. Biochem. Parasitol. 93:273-282[CrossRef][Medline]. |
| 16. | Read, L. K., and R. B. Mikkelsen. 1991. Comparison of adenylate cyclase and cAMP-dependent protein kinase in gametocytogenic and nongametocytogenic clones of Plasmodium falciparum. J. Parasitol. 77:346-352[CrossRef][Medline]. |
| 17. |
Robertson, L. S., and G. R. Fink.
1998.
The three yeast A kinases have specific signaling functions in pseudohyphal growth.
Proc. Natl. Acad. Sci. USA
95:13783-13787 |
| 18. | Schrammel, A., S. Behrends, K. Schmidt, D. Koesling, and B. Mayer. 1996. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol. Pharmacol. 50:1-5[Abstract]. |
| 19. |
Silva, N. M.,
R. T. Gazzinelli,
D. A. Silva,
E. A. Ferro,
L. H. Kasper, and J. R. Mineo.
1998.
Expression of Toxoplasma gondii-specific heat shock protein 70 during in vivo conversion of bradyzoites to tachyzoites.
Infect. Immun.
66:3959-3963 |
| 20. | Soderbom, F., and W. F. Loomis. 1998. Cell-cell signaling during Dictyostelium development. Trends Microbiol. 6:402-406[CrossRef][Medline]. |
| 21. | Soete, M., D. Camus, and J. F. Dubremetz. 1994. Experimental induction of bradyzoite-specific antigen expression and cyst formation by the RH strain of Toxoplasma gondii in vitro. Exp. Parasitol. 78:361-370[CrossRef][Medline]. |
| 22. |
Wang, B., and A. Kuspa.
1997.
Dictyostelium development in the absence of cAMP.
Science
277:251-254 |
| 23. | Weiss, L. M., D. Laplace, P. M. Takvorian, H. B. Tanowitz, A. Cali, and M. Wittner. 1995. A cell culture system for study of the development of Toxoplasma gondii bradyzoites. J. Eukaryot. Microbiol. 42:150-157[Medline]. |
| 24. | Weiss, L. M., D. LaPlace, H. B. Tanowitz, and M. Wittner. 1992. Identification of Toxoplasma gondii bradyzoite-specific monoclonal antibodies. J. Infect. Dis. 166:213-215[Medline]. |
| 25. |
Weiss, L. M.,
Y. F. Ma,
P. M. Takvorian,
H. B. Tanowitz, and M. Wittner.
1998.
Bradyzoite development in Toxoplasma gondii and the hsp70 stress response.
Infect. Immun.
66:3295-3302 |
| 26. | Welsh, G. I., C. Wilson, and C. Proud. 1996. GSK3: a SHAGGY frog story. Trends Cell Biol. 6:274-279. |
| 27. | Yahiaoui, B., F. Dzierszinski, A. Bernigaud, C. Slomianny, D. Camus, and S. Tomavo. 1999. Isolation and characterization of a subtractive library enriched for developmentally regulated transcripts expressed during encystation of Toxoplasma gondii. Mol. Biochem. Parasitol. 99:223-235[CrossRef][Medline]. |
| 28. |
Zhang, Y. W.,
S. K. Halonen,
Y. F. Ma,
M. Wittner, and L. M. Weiss.
2001.
Initial characterization of CST1: a Toxoplasma gondii cyst wall glycoprotein.
Infect. Immun.
69:501-507 |
| 29. | Zhang, Y. W., K. Kim, Y. F. Ma, M. Wittner, H. B. Tanowitz, and L. M. Weiss. 1999. Disruption of the Toxoplasma gondii bradyzoite-specific gene BAG1 decreases in vivo cyst formation. Mol. Microbiol. 31:691-701[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»